Stockreport

Biohaven (BHVN) Is Down 5.9% After New BHV-1510 Combo Data - What's Changed [Yahoo! Finance]

Biohaven Pharmaceutical Holding Company Ltd. Common Shares  (BHVN) 
Last biohaven pharmaceutical holding company ltd. common shares earnings: 2/25 04:45 pm Check Earnings Report
US:NYSE Investor Relations: investors.biohavenpharma.com
PDF antibody drug conjugate BHV-1510 combined with Regeneron's anti-PD-1 therapy cemiplimab across multiple solid tumors. The data showed a high confirmed objective respon [Read more]